SCI时时刷

search
Novel approach to bone comorbidity in resistant acromegaly
Novel approach to bone comorbidity in resistant acromegaly
Active acromegaly may lead to irreversible complications. Among them, acromegaly osteopathy and fragility (vertebral and h...
Hypopituitarism and COVID-19
Hypopituitarism and COVID-19
This review aims to collect and examine recent research findings regarding hypopituitarism and COVID-19, focusing on the v...
Modern approach to bone comorbidity in prolactinoma
Modern approach to bone comorbidity in prolactinoma
Prolactinomas account for more than half of pituitary adenomas, and besides their clinical impact on fertility and gonadal...
Cushing’s syndrome and COVID-19
Cushing’s syndrome and COVID-19
This review aims to present current data on the course of COVID-19 in patients with Cushing syndrome (CS) and discuss trea...
Approach to the patient with controlled acromegaly and acromegalic arthropathy: clinical diagnosis and management
Approach to the patient with controlled acromegaly and acromegalic arthropathy: clinical diagnosis and management
Following the description of an illustrative case of a 70-year-old female patient with longstanding active acromegaly and ...
Growth hormone and bone: a basic perspective
Growth hormone and bone: a basic perspective
Growth hormone is fundamental for growth during childhood and for maintaining bone mass and homeostasis in the adults. GH ...
TSH-secreting pituitary adenomas and bone
TSH-secreting pituitary adenomas and bone
TSH-secreting pituitary adenoma (TSHoma) is the rarest functioning pituitary tumor, with an increasing incidence over the ...
Hypophysitis in COVID-19: a systematic review
Hypophysitis in COVID-19: a systematic review
This systematic review aims to collect and examine recent research findings regarding hypophysitis in COVID-19 patients. W...
Efficacy and safety of pasireotide treatment in acromegaly: A systematic review and single arm meta-analysis
Efficacy and safety of pasireotide treatment in acromegaly: A systematic review and single arm meta-analysis
Acromegaly is a rare chronic endocrine disorder associated with significant comorbidities. Many patients fail to achieve b...
Sleep disruption in patients with active and treated endogenous Cushing’s syndrome
Sleep disruption in patients with active and treated endogenous Cushing’s syndrome
The hypothalamic-pituitary-adrenal axis is a critical regulator of circadian rhythm in humans. Impaired sleep adversely af...
Desmopressin dose requirements in patients with permanent arginine vasopressin deficiency: a tertiary center experience
Desmopressin dose requirements in patients with permanent arginine vasopressin deficiency: a tertiary center experience
The desmopressin daily dose requirement is highly variable among patients with arginine vasopressin (AVP) deficiency (i.e....
Natural history of untreated microprolactinomas
Natural history of untreated microprolactinomas
Cite this articleSadek, M., Clarke, D.B. & Imran, S.A. Natural history of untreated microprolactinomas. ...
SARS-CoV-2 infection and vaccination in patients with pituitary diseases: the experience of a Brazilian reference center
SARS-CoV-2 infection and vaccination in patients with pituitary diseases: the experience of a Brazilian reference center
To evaluate the prevalence and characteristics of SARS-CoV-2 infection, and the prevalence, efficacy, and safety of anti-S...
GLP-1 receptor agonists may enhance the effects of desmopressin in individuals with AVP deficiency: a case series and proposed mechanism
GLP-1 receptor agonists may enhance the effects of desmopressin in individuals with AVP deficiency: a case series and proposed mechanism
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have diverse effects on sodium and water homeostasis. They decrease ...
Cardiovascular risk and glucocorticoids: a Dutch National Registry of growth hormone treatment in adults with growth hormone deficiency analysis
Cardiovascular risk and glucocorticoids: a Dutch National Registry of growth hormone treatment in adults with growth hormone deficiency analysis
Patients with hypopituitarism are at increased cardiovascular risk, in part because of growth hormone deficiency (GHD), bu...
Long COVID and pituitary dysfunctions: a bidirectional relationship?
Long COVID and pituitary dysfunctions: a bidirectional relationship?
Long COVID is a novel emerging syndrome known to affect multiple health areas in patients previously infected by SARS-CoV-...
Skeletal fragility in pituitary disease: how can we predict fracture risk?
Skeletal fragility in pituitary disease: how can we predict fracture risk?
Pituitary hormones play a crucial role in regulating skeletal physiology, and skeletal fragility is a frequent complicatio...
Syndrome of inappropriate antidiuresis/hyponatremia in COVID-19
Syndrome of inappropriate antidiuresis/hyponatremia in COVID-19
Hyponatremia is the most frequent electrolyte alteration among hospitalized patients and it has been reported in 20–...
Vitamin D in pituitary driven osteopathies
Vitamin D in pituitary driven osteopathies
The evidence that pituitary hormones may bypass peripheral endocrine glands to exert remarkable effects on the skeleton is...
Recovery from hypogonadism in men with prolactinoma treated with dopamine agonists
Recovery from hypogonadism in men with prolactinoma treated with dopamine agonists
In men with prolactinoma treated with dopamine agonists (DA), the extent, timeline, and predictive factors of gonadotropic...
“Intrasellar tumor-to-tumor metastasis: A single center experience with a systematic review”
“Intrasellar tumor-to-tumor metastasis: A single center experience with a systematic review”
This study investigates the rare occurrence of tumor-to-tumor metastasis in Pituitary Neuroendocrine Tumors (PitNETs), als...
Somapacitan-induced reversible lipoatrophy in an adult woman with hypopituitarism
Somapacitan-induced reversible lipoatrophy in an adult woman with hypopituitarism
Lipoatrophy is rare adverse event (AE) in daily recombinant human growth hormone (rhGH). Data on lipoatrophy in newly deve...
Semaglutide treatment of hypothalamic obesity – a real-life data study
Semaglutide treatment of hypothalamic obesity – a real-life data study
Patients with tumors involving the hypothalamic region are at high risk of developing morbid obesity due to disturbances i...
Neuroendocrine challenges and clinical outcomes in men with chronic traumatic brain injury: a cross-sectional study
Neuroendocrine challenges and clinical outcomes in men with chronic traumatic brain injury: a cross-sectional study
Marked changes in the hypothalamic-pituitary axis have been documented in patients with traumatic brain injury (TBI). Thes...
Pituitary Apoplexy: a re-appraisal of risk factors and best management strategies in the COVID-19 era
Pituitary Apoplexy: a re-appraisal of risk factors and best management strategies in the COVID-19 era
Pituitary apoplexy (PA) is a clinical syndrome caused by acute hemorrhage and/or infarction of the pituitary gland, most c...
The diverging role of O-GlcNAc transferase in corticotroph and somatotroph adenomas
The diverging role of O-GlcNAc transferase in corticotroph and somatotroph adenomas
Molecular mechanisms involved in the pathogenesis and tumor progression of pituitary adenomas (PA) remain incompletely und...
Semaglutide as a promising treatment for hypothalamic obesity: a six-month case series on four females with craniopharyngioma
Semaglutide as a promising treatment for hypothalamic obesity: a six-month case series on four females with craniopharyngioma
Patients with hypothalamic pathology often develop hypothalamic obesity, causing severe metabolic alterations resulting in...
Diagnostic, therapeutic, and prognostic characteristics of patients with acromegaly according to tumor size at diagnosis
Diagnostic, therapeutic, and prognostic characteristics of patients with acromegaly according to tumor size at diagnosis
To evaluate clinical, laboratory, radiological, therapeutic, and prognostic characteristics of patients with acromegaly ac...